tiprankstipranks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY
Germany Market

OncoZenge AB (8LY) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
OncoZenge AB’s (8LY) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting OncoZenge AB is a Sell.
OncoZenge AB’s (8LY) 20-Day exponential moving average is 0.31, while OncoZenge AB’s (8LY) share price is €0.32, making it a Buy.
OncoZenge AB’s (8LY) 50-Day exponential moving average is 0.30, while OncoZenge AB’s (8LY) share price is €0.32, making it a Buy.

OncoZenge AB (8LY) Pivot Points

Jul 23, 2024, 07:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.33
0.33
0.33
0.33
0.33
0.33
0.33
Fibonacci
0.33
0.33
0.33
0.33
0.33
0.33
0.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoZenge AB (8LY) Moving Averages

Jul 23, 2024, 07:10 PM
Period
Simple
Exponential
MA5
0.32Sell
0.32Sell
MA10
0.32Buy
0.32Buy
MA20
0.30Buy
0.31Buy
MA50
0.30Buy
0.30Buy
MA100
0.31Buy
0.30Buy
MA200
0.30Buy
0.28Buy
OncoZenge AB’s (8LY) 10-Day exponential moving average is 0.32, while OncoZenge AB’s (8LY) share price is €0.32, making it a Buy.
OncoZenge AB’s (8LY) 100-Day exponential moving average is 0.30, while OncoZenge AB’s (8LY) share price is €0.32, making it a Buy.
OncoZenge AB’s (8LY) stock price is €0.32 and OncoZenge AB’s (8LY) 50-day simple moving average is 0.30, creating a Buy signal.
OncoZenge AB’s (8LY) stock price is €0.32 and OncoZenge AB’s (8LY) 100-day simple moving average is 0.31, creating a Buy signal.
OncoZenge AB’s (8LY) stock price is €0.32 and OncoZenge AB’s (8LY) 200-day simple moving average is 0.30, creating a Buy signal.

OncoZenge AB (8LY) Technical Indicators

Jul 23, 2024, 07:10 PM
Name
Value
Implied Action
RSI (14)
56.17
Neutral
STOCH (9,6)
76.47
Neutral
STOCHRSI (14)
85.33
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
17.00
Buy
Williams %R
-32.14
Buy
CCI (14)
61.00
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
61.34
Neutral
ROC
10.34
Buy
OncoZenge AB’s (8LY) Relative Strength Index (RSI) is 56.17, creating a Neutral signal.
OncoZenge AB’s (8LY) Trend Strength Indicator (ADX) is 17.00, creating a Buy signal.
OncoZenge AB’s (8LY) Commodity Channel Index (CCI) is 61.00, creating a Neutral signal.
OncoZenge AB’s (8LY) Price Rate of Change (ROC) is 10.34, creating a Buy signal.

FAQ

Is 8LY a Buy, Hold, or Sell?
Based on 8LY’s technical indicators, 8LY is a Buy.
    What is 8LY’s RSI (14)?
    8LY’s RSI (14) is 56.17, which suggests 8LY is a Neutral.
      What is 8LY’s MACD?
      8LY’s MACD is <0.01, which suggests 8LY is a Sell.
        What is 8LY’s 5-day moving average?
        8LY’s 5-day moving average is 0.32, which suggests 8LY is a Sell.
          What is 8LY’s 20-day moving average?
          8LY 20-day moving average is 0.30, which suggests 8LY is a Buy.
            What is 8LY’s 50-day moving average?
            8LY’s 50-day moving average is 0.30, which suggests 8LY is a Buy.
              What is 8LY’s 200-day moving average?
              8LY’s 200-day moving average is 0.30, which suggests 8LY is a Buy.
                What is 8LY’s Williams % R (14)?
                8LY’s Williams % R (14) is -32.14, which suggests 8LY is a Buy.
                  What is 8LY’s CCI (14)?
                  8LY’s CCI (14) is 61.00, which suggests 8LY is a Neutral.
                    What is the share price of OncoZenge AB?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis